A comparison of fibrosis progression in chronic liver diseases.
about
The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosisInvolvement of matrix metalloproteinases (MMPs) and inflammasome pathway in molecular mechanisms of fibrosisTelomeres, NAFLD and Chronic Liver DiseaseMultidisciplinary View of Alcohol Use Disorder: From a Psychiatric Illness to a Major Liver DiseaseRole of liver transplantation in human immunodeficiency virus positive patientsUpdate on Alcoholic HepatitisDiagnosis and Management of Alcoholic Liver DiseasePerinatal exposure to a high-fat diet is associated with reduced hepatic sympathetic innervation in one-year old male Japanese macaquesThe Role of Obstetrician/Gynecologists in the Management of Hepatitis C Virus InfectionNew Concepts on Pathogenesis and Diagnosis of Liver Fibrosis; A Review ArticleState-of-the-art imaging of liver fibrosis and cirrhosis: A comprehensive review of current applications and future perspectivesHepatocyte IKK2 protects Mdr2-/- mice from chronic liver failurePerformance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient dataAttenuating effect of Ginkgo biloba leaves extract on liver fibrosis induced by thioacetamide in miceA new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis BHepatic stellate cells: protean, multifunctional, and enigmatic cells of the liverLiver fibrosis and protection mechanisms action of medicinal plants targeting apoptosis of hepatocytes and hepatic stellate cellsLiver fibrosis and mechanisms of the protective action of medicinal plants targeting inflammation and the immune response.Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B VirusValidation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic Hepatitis.Diagnosis of alcoholic liver disease.Assessment of hepatic fibrosis regression by transient elastography in patients with chronic hepatitis B treated with oral antiviral agentsMeta-analyses of FibroTest diagnostic value in chronic liver disease.Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV-HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study.Alcohol Consumption in Concomitant Liver Disease: How Much is Too Much?German cohort of HCV mono-infected and HCV/HIV co-infected patients reveals relative under-treatment of co-infected patients.Hepatitis C: is a vaccine the solution?Estrogen receptor alpha gene polymorphisms and risk of HBV-related acute liver failure in the Chinese populationEffects of β-sitosterol derived from Artemisia capillaris on the activated human hepatic stellate cells and dimethylnitrosamine-induced mouse liver fibrosisAssociations of IFN-γ rs2430561 T/A, IL28B rs12979860 C/T and ERα rs2077647 T/C polymorphisms with outcomes of hepatitis B virus infection: a meta-analysis.Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection.Willingness to undergo a repeat liver biopsy among HIV/hepatitis C virus-coinfected and hepatitis C virus-monoinfected patients.Interleukin-6 is associated with noninvasive markers of liver fibrosis in HIV-infected patients with alcohol problemsPNPLA3 I148M (rs738409) genetic variant and age at onset of at-risk alcohol consumption are independent risk factors for alcoholic cirrhosis.qFibrosis: a fully-quantitative innovative method incorporating histological features to facilitate accurate fibrosis scoring in animal model and chronic hepatitis B patientsDiagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease.Cystatin C and creatinine in an HIV cohort: the nutrition for healthy living study.Hepatic Fibrosis Progression in HIV-Hepatitis C Virus Co-Infection--The Effect of Sex on Risk of Significant Fibrosis Measured by Aspartate-to-Platelet Ratio Index.An appraisal of the histopathological assessment of liver fibrosis
P2860
Q25257576-99A3A2AA-6065-4199-A593-5440ABC76C82Q26744390-A27EC4C4-4286-4B3D-9184-829BA9364F45Q26753037-B311B63C-45CA-46A5-89A4-290D26B35463Q26771090-84E33D25-9393-47C3-816F-631BA4C74527Q26775931-DC9E351B-677D-4324-A00A-8232CE3EB8B9Q26779121-C0B4C4F6-9F0C-4A41-A37C-2E346F0FE212Q26781876-981E9A1B-AB31-411D-9526-9759BECF692DQ27312641-8061D7AD-4216-433C-BC7C-11D346E427D6Q27486939-975F760F-651E-4BCD-8F6E-98497B3FB73EQ28070168-07E5BE02-5FF2-447B-96F6-095908F87D76Q28085479-2D140CDE-E835-42B7-90A2-AE190F3E837EQ28477512-AAE8C2C3-47E0-436E-9229-BBD3120B2D7BQ28481485-099812B7-F4D8-47AD-A91A-56395A519C6CQ28727196-01525FFA-BFCE-4A08-866D-4CC50C23C4B1Q28741501-875C203E-4DA6-410D-BC5C-59B7F2C49249Q29616840-6B0421C6-F957-420D-BF55-2D7E0496EB15Q30369750-8A186EB8-69D3-454E-AFFE-D736B8AB0D34Q30374500-137E58E8-203B-4CFE-BD40-7219249B52E3Q30375738-DD95542A-A712-4A31-8D0D-F682FAD5FB72Q30404990-A3DE83FF-C949-40AA-838A-E407E9BFDA15Q30431186-E1C0A652-F095-4CCD-BECD-7A41CBCAC13CQ30439873-98D43366-7F2F-4A3D-BE49-8E1B68A9D5FAQ33302708-93999649-1968-435B-903B-827D33551A64Q33562288-28F3EEE7-71ED-4354-B1B5-356F9FAA512EQ33787655-2882B4D2-BFC6-478A-B584-EE2FBEB0BAECQ33840930-73730FA9-B42B-4DBA-9172-2C1C27D9AAC5Q33863006-467CEED2-803D-4103-B03B-1BEB9647E719Q34290831-7AB549EE-5AC8-4EC3-9112-C8FBB179CC74Q34315221-698571A4-71B5-44EF-926A-DD1C7DCF0572Q34320250-2A95FB40-3BF2-42E4-BB6D-B5C4E74A24E4Q34604379-C08AB468-0587-4591-8422-0C672FC62102Q34606036-C2AFA751-B480-4DB7-98FD-ED9168FE7EE7Q34670502-4F432860-9151-4538-BD60-E3DE03295AD5Q34677793-C505A71D-1404-4D53-A08E-3D17B8F10E24Q34693476-FF412AE3-7AAB-4F79-889E-08FF81F099DFQ34785127-4F67FD78-448B-4770-946B-BB55E5644F53Q34893571-7B53AD9C-0D36-4170-8455-CDDBA37C537FQ35604023-1070F9D4-CA6A-4E50-8754-8AD6BED74D63Q35668307-F9069F55-64D4-447F-B78C-EF539ECFB4CFQ35760393-B17F0675-3C7E-4593-A39C-0E4CE450D3BE
P2860
A comparison of fibrosis progression in chronic liver diseases.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
A comparison of fibrosis progression in chronic liver diseases.
@en
A comparison of fibrosis progression in chronic liver diseases.
@nl
type
label
A comparison of fibrosis progression in chronic liver diseases.
@en
A comparison of fibrosis progression in chronic liver diseases.
@nl
prefLabel
A comparison of fibrosis progression in chronic liver diseases.
@en
A comparison of fibrosis progression in chronic liver diseases.
@nl
P2093
P50
P1476
A comparison of fibrosis progression in chronic liver diseases.
@en
P2093
Antonio Chedid
Arndt Vogel
Frédérique Capron
Marie-Hélène Tainturier
Michael Manns
Mona Muntenau
PANFIBROSIS Group
Renée Poupon
Robert P Myers
Vlad Ratziu
P304
P356
10.1016/S0168-8278(02)00413-0
P577
2003-03-01T00:00:00Z